Condition
Sclerosing Cholangitis
Total Trials
5
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
P 1 (1)
P 2 (1)
Trial Status
Completed3
Not Yet Recruiting1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06670547Not Yet Recruiting
Spanish Registry of Quality Indicators and Adverse Events of Endoscopic Retrograde Cholangiopancreatography
NCT05187312Recruiting
Registry for Advanced Endoscopy
NCT01556555CompletedPrimary
Clinical Utility of the Spyglass System in Primary Sclerosing Cholangitis (PSC)
NCT01988506Phase 2Completed
Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases
NCT02424175Phase 1CompletedPrimary
Fecal Microbiota Transplantation for the Treatment of Primary Sclerosing Cholangitis.
Showing all 5 trials